Menu
Subscribe - Individual
Subscribe - Biotech Premium (Corporate)
Home
About Us
Subscribe
Subscribe Individual
Subscribe Biotech Premium (Corporate)
Premium Biotech Coverage
Current News
Special Features
Company Index
Index Table
Summit
19th Bioshares Biotech Summit
Summit History
Contact
Contact Us
Email Alerts
Categories
Categories
Actinogen (ACW)
Adalta (1AD)
Amplia Therapeutics (ATX)
Anteris Technologies (AVR)
Aroa Biosurgery (ARX)
Blinklab (BB1)
Blog
Botanix (BOT)
Chimeric Therapeutics (CHM)
Clever Culture Systems (CC5)
Clinuvel Pharmaceuticals (CUV)
Cogstate (CGS)
Dimerix (DXB)
EBR Systems (EBR)
Immuron (IMC)
Imugene (IMU)
Island Pharmaceuticals (ILA)
Neuren Pharmaceuticals (NEU)
Patrys (PAB)
Syntara (SNT) (previously Pharmaxis, PXS)
Uncategorized
June 3rd, 2025
Chimeric Therapeutics to Raise $6.6 Million with Early Encouraging Data Emerging
Read More
May 14th, 2025
Chimeric Seeking Early Positive Data for Commercial Deal
Read More
March 6th, 2025
Chimeric Therapeutics Receives Sizeable Donation
Read More
November 3rd, 2023
Chimeric Therapeutics - Four Phase Ib Studies in 2024 Ahead of Partnering Deals
Read More
May 19th, 2023
Chimeric Therapeutics Opens $6.3 Million Capital Raise
Read More
April 6th, 2023
Chimeric Therapeutics - Viral Vector Manufacturing Achieved
Read More
May 25th, 2022
Chimeric Antigen Receptor T Cell Therapies
Read More
April 1st, 2022
Chimeric Therapeutics Raises $14 Million in Rights Issue
Read More
February 14th, 2022
Chimeric Therapeutics Reports Good Data in Second Patient Cohort
Read More
Pages
1
